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Abstract—The unsaturated fatty acid, oleate exhibits
anorexigenic properties reducing food intake and hepatic
glucose output. However, its mechanism of action in the
hypothalamus has not been fully determined. This study
investigated the eﬀects of oleate and glucose on GT1-7
mouse hypothalamic cells (a model of glucose-excited
(GE) neurons) and mouse arcuate nucleus (ARC) neurons.
Whole-cell and perforated patch-clamp recordings,
immunoblotting and cell energy status measures were used
to investigate oleate- and glucose-sensing properties of
mouse hypothalamic neurons. Oleate or lowered glucose
concentration caused hyperpolarization and inhibition of ﬁr-
ing of GT1-7 cells by the activation of ATP-sensitive K+
channels (KATP). This eﬀect of oleate was not dependent
on fatty acid oxidation or raised AMP-activated protein
kinase activity or prevented by the presence of the UCP2
inhibitor genipin. Oleate did not alter intracellular calcium,
indicating that CD36/fatty acid translocase may not play a
role. However, oleate activation of KATP may require ATP
metabolism. The short-chain fatty acid octanoate was
unable to replicate the actions of oleate on GT1-7 cells.
Although oleate decreased GT1-7 cell mitochondrial mem-
brane potential there was no change in total cellular ATP
or ATP/ADP ratios. Perforated patch and whole-cell record-
ings from mouse hypothalamic slices demonstrated that
oleate hyperpolarized a subpopulation of ARC GE neurons
by KATP activation. Additionally, in a separate small popula-
tion of ARC neurons, oleate application or lowered glucose
concentration caused membrane depolarization. In conclu-
sion, oleate induces KATP-dependent hyperpolarization and
inhibition of ﬁring of a subgroup of GE hypothalamic
neurons without altering cellular energy charge.  2017
The Authors. Published by Elsevier Ltd on behalf of IBRO.
This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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INTRODUCTION
The hypothalamus is critical for the continuous regulation
of whole-body glucose, lipid and energy homeostasis. To
perform this function, various hypothalamic nuclei (e.g.
arcuate (ARC), ventromedial (VMN), lateral
hypothalamic area and paraventricular) contain
neuropeptide-expressing neurons that monitor
circulating nutrients and hormone levels (Levin et al.,
2004). Scattered throughout these nuclei are subpopula-
tions of neurons that sense changes in glucose levels,
resulting in altered neuronal ﬁring and modiﬁed energy
homeostasis (Levin et al., 1999). There are two main sub-
types of glucose-sensing hypothalamic neurons that con-
tribute to these homeostatic mechanisms: neurons
excited (glucose-excited (GE)) and inhibited (glucose-
inhibited (GI)) by increased levels of glucose. GE neurons
utilize ATP-sensitive potassium (KATP) channels (in a
manner similar to pancreatic beta cells (MacDonald
et al., 2005) to modulate their electrical activity in
response to changes in extracellular glucose concentra-
tion (Ashford et al., 1990; Wang et al., 2004; Kang
et al., 2006). It is presently unclear which ion transport
mechanism is responsible for transducing changes in glu-
cose concentration to modify electrical activity in GI neu-
rons (Gonzalez et al., 2009). These glucose-sensing
neurons, in particular GE neurons, play important roles
in the feeding response to glucoprivation (as suppression
of glucokinase (GK) diminishes the glucoprivic stimulation
of feeding (Dunn-Meynell et al., 2009), and liver glucose
production (Parton et al., 2007) and have been strongly
implicated in the detection of hypoglycemia and subse-
quent generation of counterregulatory responses (Beall
et al., 2012). For example, loss of the KATP channel sub-
unit, KIR6.2, causes near complete suppression of gluca-
gon responses to hypoglycemia, which is driven by the
loss of KATP on neural cells (Miki et al., 2001).
Similarly, energy status (i.e. lipid level) is also
communicated continuously to the hypothalamus. This
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is performed, at least in part, by hypothalamic neurons
responding to changes in the concentrations of
circulating hormones (e.g. leptin and insulin), the levels
of which correlate with adipose tissue depot size. It is
this latter communication system that is considered to
become faulty in obesity (Frederich et al., 1995). How-
ever, circulating lipids, such as long-chain fatty acids,
have also been demonstrated to directly act on hypotha-
lamic centers to modulate feeding and hepatic glucose
output (Obici et al., 2002; Lam et al., 2005). Circulating
levels can be acutely elevated, such as during fasting or
hypoglycemia, where lipolysis is elevated (De Feo et al.,
1989), therefore it is plausible that some neurons have
a capacity to detect both reduced glucose and elevated
lipid levels. Indeed the long-chain fatty acid, oleate alters
ARC neuron neuropeptide expression, electrical activity
and within glucosensing neurons, can alter intracellular
calcium signaling via CD36/fatty acid translocase
(Obici et al., 2002; Morgan et al., 2004; Wang et al.,
2006; Le Foll et al., 2009). Furthermore, long-chain fatty
acids are activators of KATP channels in pancreatic beta
cells (Larsson et al., 1996) and hypothalamic-delivered
oleate suppresses hepatic glucose production in a
KATP-dependent manner (Obici et al., 2002). A previous
study suggested that oleate alters the excitability of
ARC neurons in a glucose-concentration-dependent man-
ner suggesting interaction at the level of cellular nutrient
metabolism (Wang et al., 2006). In addition, the central
eﬀects of fatty acids on glucose homeostasis have been
ascribed to neuronal fatty acid metabolism (Obici et al.,
2003; Cruciani-Guglielmacci et al., 2004).
Alternatively, fatty acids can regulate the activity of
mitochondrial uncoupling proteins (UCP) (Echtay et al.,
2001), including the neuronal enriched UCP isoforms,
UCP4 and UCP5 (Hoang et al., 2012). In the pancreatic
beta cell, UCP2 has been implicated in regulating
glucose-sensing behavior (Lameloise, 2001; Zhang,
2001; Parton et al., 2007). Indeed, oleate modulates the
expression of UCP2 and alters glucose-dependent insulin
secretion in pancreatic beta cells and beta cell lines
(Medvedev et al., 2002; Oprescu et al., 2007). Impor-
tantly, UCP2 has been shown to regulate the glucose-
sensing behavior of GE neurons and alter whole-body
glucose homeostasis (Parton et al., 2007). Consequently,
in order to explore the mechanisms by which oleate mod-
iﬁes neuronal excitability we have examined the interplay
between nutrient-dependent pathways and oleate
responses in mouse GE-type neurons.
EXPERIMENTAL PROCEDURES
Cell culture
Immortalized mouse hypothalamic GnRH secreting GT1-
7 cells (Pamela Mellon, San Diego, California, USA (Lam
et al., 2005) were maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM; Sigma–Aldrich, Gillingham,
UK)) with 10% fetal bovine serum (PAA Laboratories,
Yeovil, UK & Hyclone, Pasching, Austria) as described
(Mirshamsi et al., 2004).
Immunoblotting
GT1-7 cells, seeded in 6-well dishes, were serum-starved
for three hours with DMEM replaced by saline and then
treated with nutrients (0–100 lM oleate or 2.5/0.1 mM
glucose) for various times as described in the results
section. We used oleate concentrations in the low
micromolar (10–100 lM) as plasma concentrations of
total free fatty acids have been estimated within the
range of 350–500 lM under normal circumstances
(Richieri and Kleinfeld, 1995; Mai et al., 2006; Abdul-
Ghani et al., 2008) and, in type 1 diabetes, can reach
levels of more than 1200 lM (Boden, 1998). In human
CSF levels of oleate have been reported to be >10 lM
in non-diabetic populations (Levi et al., 2013), and may
be expected to reach much higher levels in type 1 diabetic
patients. In rats, brain glucose levels have been esti-
mated at 2.5 and 0.1 mM during euglycemia and
hypoglycemia, respectively (Silver and Erecinska, 1994).
Protein isolation and immunoblotting procedures were
as described previously (Mirshamsi et al., 2004). Brieﬂy,
protein lysates were subjected to SDS–PAGE, electro-
transferred to nitrocellulose membranes, and probed with
primary antibodies against p-AMPKa (Thr172; 1:1000), p-
ACC (Ser79; 1:1000), actin (1:5000), UCP4 (1:1000) and
UCP5 (1:1000). All antibodies were obtained from Cell
Signalling Technology Inc. (New England Biolabs, Hitchin,
UK) except UCP4 and UCP5, which were obtained from
Acris Antibodies (Herford, Germany). Proteins were
detected with horseradish peroxidase-conjugated Goat
anti-Rabbit IgG and immunoreactive proteins identiﬁed by
chemiluminescence. Gel protein bands were quantiﬁed by
densitometry, where total density was determined with
respect to constant area, background subtracted and aver-
age relative band density calculated.
Hypothalamic slice preparation
All animal procedures conformed to the UK Animals
Scientiﬁc Procedures Act (1986) and were approved by
the University of Dundee institutional ethics review
committee. Wild-type male C57Bl/6 mice (6–20 weeks
old) were killed by cervical dislocation and the brains
rapidly removed and submerged in an ice cold slicing
solution as described previously (Hisadome et al.,
2009). Brieﬂy, hypothalamic coronal slices containing
the ARC (350 lm) were prepared using a Vibratome (St
Louis, MO, USA) and stored at room temperature (22–
25 C) in an external solution containing (in mM): NaCl
125, KCl 2.5, NaH2PO4 1.25, NaHCO3 25, CaCl2 2, MgCl2
1, D-Glucose 10, D-Mannitol 15, ascorbate 1 and pyru-
vate 3, equilibrated with 95% O2, 5% CO2, pH 7.4. Imme-
diately before use, brain slices were transferred to the
recording chamber of an upright Zeiss Axioskop-2 FS
plus microscope and continuously perfused with a modi-
ﬁed external solution (containing 0.5 mM CaCl2 and
2.5 mM MgCl2, no ascorbate and pyruvate) at a constant
ﬂow rate of 5–10 ml min1 and bath temperature of 33 C.
Electrophysiology
GT1-7 cells were visualized by phase contrast and
individual neurons of mouse hypothalamic slices by
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diﬀerential interference contrast optics. Whole-cell patch-
clamp recordings were performed using borosilicate
pipettes (4–8 MO) ﬁlled with an internal solution
containing (mM): K-gluconate 130, KCl 10, EGTA 0.5,
HEPES 10, NaCl 1, MgCl2 3, CaCl2 0.28, Na2-ATP 3,
Tris-GTP 0.3, and phosphocreatine 14; pH 7.2 for ARC
neurons and with KCl 140, EGTA 10, HEPES 10, MgCl2
5, CaCl2 3.8, and Na2-ATP 3; pH 7.2 for GT1-7 cells.
Hypothalamic neuron recordings were made in external
solution at 33 C and GT1-7 cell recordings at room
temperature (22–25 C) in saline containing (in mM):
NaCl 135, KCl 5, MgCl2 1, CaCl2 1, HEPES 10, glucose
2.5 (pH 7.4). For perforated patch-clamp recordings 30–
35 lg/ml amphotericin B and/or 2.5 mg/ml gramicidin
was included in the internal solution in the absence of
Na2-ATP. As previously described, voltage and current
commands were manually or externally driven using
pCLAMP 9.2 software and injected into neurons via the
patch-clamp ampliﬁer (Axopatch 200B; Molecular
Devices, Sunnyvale CA, USA). In the whole-cell current-
clamp conﬁguration, hyperpolarising current pulses (5–
20 pA amplitude at a frequency of 0.05 Hz) were used
to monitor changes in input resistance. For voltage-
clamp recordings the membrane potential was held at
70 mV and voltage steps (20 mV increments, 200 ms
duration) applied over the voltage range of 160 to 20
or +80 mV. Voltage-clamp protocols were carried out
immediately after whole-cell formation, prior to and
during exposure to drugs and/or oleate or altered
glucose concentration (following achievement of
maximal responses). At least 10 min of stable control
data were recorded before the application of drugs or
oleate, which were added to the external/saline solution
and applied to slices or GT1-7 cells via a superfusion
system. In some slice experiments oleate was applied
locally via pressure ejection using a broken-tipped
pipette positioned above the recording neuron.
Nucleotide measurements
GT1-7 cells were seeded onto black-walled 96-well plates
at 1  104 cells per well. Total ATP measurements were
made using ATPLite assay kit (Perkin-Elmer, Seer
Green, UK), as per the manufacturer’s protocol, with
minor modiﬁcations. Brieﬂy, cells were lyzed with
shaking, using 40 ll of mammalian cell lysis buﬀer for
10 min at 700 rpm, followed by the addition of 40 ll of
ATP substrate solution. For ATP/ADP ratios, cells were
plated as for total ATP measurements. Ratios were
determined using an ATP/ADP ratio kit (Sigma–Aldrich,
Gillingham, UK) as per the manufacturer’s instructions.
Mitochondrial membrane potential
GT1-7 cells were seeded on to glass-bottom dishes (In
Vitro Scientiﬁc, CA, USA) 24 h prior to study. JC-1 was
used as per the manufacturer’s protocol with minor
modiﬁcations. Brieﬂy, cells were pre-incubated with
2 lg/ml JC-1 for 1 h at 37 C in a 95% O2/5% CO2
humidiﬁed incubator before washing twice with saline
containing 10 mM glucose and studied immediately.
Images were captured on a Leica SP5 laser scanning
confocal microscope and ﬂuorescence intensity
analyzed using the standard Leica LAS AF software and
GraphPad Prism 5 for statistical analyses.
Non-ratiometric calcium imaging
GT1-7 cells were seeding into 96-well plates at
2  105 cells per well. Cells were loaded with Fluo4
Direct (ThermoFisher, UK) for 1 h at 37 degrees.
Fluorescence was monitored using a Pheratar FS
multifunction plate reader (BMG Labtech, Aylesbury,
Buckinghamshire, UK), with oleate added by injection
and cells maintained at 37 degrees during the imaging
protocol. Fluorescence is presented as relative
ﬂuorescent units (RFU), with ﬂuorescence at the zero
point being normalized to 1.
Chemicals
Amphotericin B, AMP-PNP, FA-free bovine serum
albumin, diazoxide, etomoxir, gramicidin, malonyl-CoA,
octanoic acid, oleic acid, and tolbutamide were
purchased from Sigma–Aldrich. Compound C was
obtained from Merck Chemicals Ltd (Nottingham, UK).
Genipin was purchased from Wako Chemicals
(Eastleigh, UK) and JC-1 was obtained from Thermo
Fisher Scientiﬁc (Renfrew, UK). Oleate was prepared as
a 10 mM stock solution containing 5% NEFA-free BSA.
Statistics
In slice recordings, hypothalamic neurons responding to
drugs, oleate or altered glucose concentration were
distinguished from non-responding neurons based on
the criterion that the change in membrane potential
(DVm) induced by the challenge was ± three times the
standard deviation of the mean membrane potential
prior to the challenge. Results are expressed as the
mean ± S.E.M. of the deﬁned responses, with the
number of cells studied. Statistical signiﬁcance was
determined by Student’s t-test or ANOVA followed by
Bonferroni’s post hoc test where appropriate. Changes
in protein phosphorylation in Western blot experiments
were analyzed using a one-sample t-test for multiple
comparisons with respect to control. A P value of less
than 0.05 was considered statistically signiﬁcant.
RESULTS
Mouse hypothalamic GT1-7 cells exhibit GE behavior
and are oleate-sensitive
Attempting to study the mechanism(s) by which oleate
alters ARC neuron excitability is diﬃcult when recording
from unidentiﬁed neurons in a hypothalamic slice.
Therefore, we utilized the mouse hypothalamic cell line,
GT1-7, which exhibits GE-type properties. We have
previously demonstrated that this neuronal cell line
shows graded electrical responses over a physiological
range of glucose concentrations and that these
responses can be modulated by pharmacological
manipulation of the classical components of glucose-
sensing, namely glucokinase, adenosine 50-monopho
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sphate-activated protein kinase (AMPK) and KATP (Beall
et al., 2012). They therefore represent an excellent model
for studying the mechanisms through which oleate may
alter neuron excitability.
In GT1-7 cells, a hypoglycemic challenge (0.1 mM
glucose) of 30 min resulted in increased AMPK
phosphorylation (p-AMPK) (Fig. 1A). This was
accompanied by increased acetyl-CoA carboxylase
(ACC) phosphorylation (p-ACC), a key substrate of
AMPK, indicating increased AMPK activity. As AMPK
has been implicated as a key component of cellular
glucose sensing in hypothalamic neurons (Claret et al.,
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2007), GT1-7 neurons (Beall et al., 2012) and pancreatic
beta cells (Beall et al., 2010), we next examined whether
oleate also alters AMPK activity. Oleate (10–100 lM;
Fig. 1B) increased levels of AMPK and ACC phosphoryla-
tion with a minimum oleate concentration to elicit this
response of >50 lM (Fig. 1B). Thus, oleate mimics the
eﬀects of lowered glucose levels on p-AMPK/p-ACC
levels in GT1-7 cells over a similar time course. Conse-
quently, we next determined whether oleate also induced
cell hyperpolarisation and KATP activation in GT1-7 cells
as demonstrated previously for lowered glucose concen-
trations (Beall et al., 2012).
Hence we performed perforated patch recordings
(which minimizes disruption of normal cell glucose
metabolism) from GT1-7 cells to monitor changes in
electrical activity and ﬁring frequency. Application of
oleate (100 lM) to GT1-7 cells induced
hyperpolarization and inhibition of ﬁring (Fig. 1C).
Baseline membrane potential was 54.3 ± 3.1 mV,
which hyperpolarized to 70.0 ± 1.5 mV following
approximately 15 min of oleate treatment (n= 3,
P< 0.05), and reversed by application of tolbutamide
(200 lM) suggesting activation of KATP channels. The
lowest concentration at which oleate induced a
detectable hyperpolarization of GT1-7 cells was 50 lM
(data not shown). To determine the contribution of KATP,
we utilized whole-cell voltage-clamp, intermittent with
current-clamp recordings to examine the eﬀect of oleate
on KATP currents following attainment of the maximal
hyperpolarizing response. Firstly, oleate hyperpolarized
GT1-7 neurons (Fig. 1D upper traces) with a similar time
course to that observed in perforated patch recordings.
Secondly, this hyperpolarization was accompanied by
an increased total current (Fig. 1D lower traces), a shift
in the reversal potential from 29.2 ± 6.5 mV to 58.9
± 4.5 mV (n= 6; P< 0.01; Fig. 1E) and an increased
slope conductance (Fig. 1F). The increase in
conductance elicited by oleate was returned to control
levels by concomitant application of 200 lM tolbutamide
(n= 3; Fig. 1F). Additionally, GT1-7 cells under voltage-
clamp exposed to 100 lM oleate and subsequently
challenged by addition of the direct KATP channel
opener diazoxide (250 lM) in the continued presence of
oleate, demonstrated further cell hyperpolarization
(Fig. 1D), an additional negative shift of the reversal
potential (to 76.0 ± 2.2 mV; n= 6; P< 0.01; Fig. 1E)
with an enlarged current associated with a greater slope
conductance (Fig. 1D, F). These actions of oleate are
consistent with submaximal activation of KATP. In order
to assess whether the increase in AMPK activity drives
the oleate-mediated hyperpolarization and KATP
activation, we determined the eﬀect of oleate on whole-
cell recordings with the AMPK inhibitor (Zhou et al.,
2001), compound C (20 lM) in the pipette solution. The
presence of compound C resulted in a signiﬁcantly more
depolarized membrane potential for GT1-7 cells, in com-
parison to untreated control cells, but did not prevent ole-
ate from hyperpolarizing the cells in a tolbutamide-
dependent manner (Fig. 1G). Consequently, these data
suggest that, in contrast to lowered glucose level
(Hisadome et al., 2009), elevated AMPK activity is not
required for oleate-mediated activation of KATP channels
and cell hyperpolarization.
GT1-7 cell response to OA is independent of fatty
acid oxidation
It has previously been reported that oleate induces
depolarization and excitation of mouse ARC
proopiomelanocortin (POMC) neurons via mitochondrial
b-oxidation, raised ATP concentration and subsequent
inactivation of KATP channel activity (Jo et al., 2009). As
GT1-7 cells respond to oleate by activation of KATP and
cell hyperpolarization such a mechanism was unlikely to
also explain this outcome. Alternatively, increased fatty
acid oxidation could raise reactive oxygen species levels
(Ruiz-Ramı´rez et al., 2011; Arany et al., 2013;
Gremmels, 2015) previously implicated in pathways
leading to neuronal KATP activation (Chai and Lin,
2010). Thus in order to examine the role of fatty acid
metabolism via b-oxidation we prevented the delivery of
oleate to mitochondria by inhibition of carnitine
palmitoyltransferase-1 (CPT1). Whole-cell recordings
were used to deliver directly to the interior of the cell (drug
present in patch pipette solution), either malonyl-CoA
(50 lM) an endogenous CPT1 inhibitor (McGarry et al.,
1977) or etoxomir (100 lM) an irreversible CPT1 inhibitor
(Declercq et al., 1987). The presence of malonyl-CoA did
not signiﬁcantly alter the membrane potential of GT1-7
cells (43.9 ± 2.3 mV; n= 10; P> 0.05 vs untreated
controls), and subsequent challenge with oleate resulted
in membrane potential hyperpolarization and increased
Fig. 1. Oleate activates AMPK and KATP in glucose-sensing GT1-7 neurons. (A) Representative immunoblots showing the eﬀect of lowering
glucose concentration from 2.0 to 0.1 mM on p-AMPK and p-ACC levels with time. Bar graphs show relative mean levels of p-AMPK and p-ACC as a
function of time after challenge with 0.1 mM glucose (n= 6). (B) Representative immunoblots showing the eﬀect of increasing concentration of
oleate (10, 50 and 100 lM) on the levels of p-AMPK and p-ACC. Bar graphs show relative mean levels of p-AMPK and p-ACC as a function of oleate
concentration (n= 5–8). (C) Oleate hyperpolarizes GT1-7 cells within 5–15 min of application, an action reversed on application of tolbutamide. Bar
graph shows mean values for membrane potential of cells exposed to oleate (n= 3). (D) Whole-cell recording under current-clamp and switched to
voltage-clamp for short periods as denoted by (d) showing that the oleate (100 lM) hyperpolarization is sustained but submaximal with addition of
diazoxide (250 lM) causing further hyperpolarization (upper traces). The families of currents shown are from a holding potential of 70 mV with
tests pulses between 160 and 20 mV and obtained at times marked (d) during the experiment shown in upper traces. (E) Current–voltage
relationships formed with current amplitude values from the cell shown in (D). (F) Bar graph denotes mean slope conductance values (derived from
best ﬁt to current–voltage curves over 160 to 20 mV range) in control and after addition of 100 lM oleate, oleate + tolbutamide and oleate
+ Dzx (n= 6). (G) Eﬀect of oleate (100 lM) on the membrane potential of a GT1-7 cell in which compound C (20 lM) was present in the electrode
solution and allowed to dialyze into the cell for 20 min prior to oleate application. Note that oleate hyperpolarized the cell, which was reversed by the
addition of tolbutamide (200 lM). Bar graph shows mean values for membrane potential of cells dialyzed with compound C2 min after formation of
whole-cell conﬁguration and after 20-min dialysis, followed by the addition of oleate, tolbutamide and extensive wash (n= 4–7). Values are mean
± SEM. *p< 0.05, **p< 0.01, ***p< 0.001
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KATP conductance (Fig. 2A–C). The actions of oleate in
the presence of malonyl-CoA were similar to that of
control experiments (above), however, although the initial
(5–10 min) response to oleate in the presence of malonyl-
CoA was indistinguishable from control, we did note that
the oleate response waned with time and by 20 min was
reduced by >50% (Fig. 2A–C). This outcome could indi-
cate a delayed reduction in fatty acid oxidation by
malonyl-CoA, mediated perhaps by diﬀusion limitations.
Thus, in separate experiments, we examined the eﬀect
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of etomoxir (applied via pipette solution with a dialysis
time of at least 20 min prior to oleate challenge) and
showed that this drug had no eﬀect per se on the resting
membrane potential of GT1-7 cells and did not prevent
oleate from causing cell hyperpolarization (Fig. 2D). Con-
sequently, it appears unlikely that b-oxidation of oleate is
required to elicit the inhibition of GT1-7 cell electrical
activity. We next examined whether the short-chain fatty
acid octanoate (C8), which does not require CPT1-
dependent transport into the mitochondria for oxidation,
could mimic the hyperpolarizing eﬀect of oleate on GT1-
7 cells. Surprisingly, addition of octanoate (50 lM) to
GT1-7 cells caused a signiﬁcant depolarization, which
was reversible on washout of the fatty acid (Fig. 2E).
However, the presence of this short-chain fatty acid did
not prevent oleate from hyperpolarizing GT1-7 cells in a
tolbutamide-dependent manner (Fig. 2F). These results
indicate that GT1-7 cells respond by diﬀerent eﬀector
mechanisms to short- and long-chain fatty acids. In cal-
cium imaging studies, we found that oleate treatment
did not alter intracellular calcium (Fig. 2H) suggesting that
CD36 is not involved in this response.
Oleate hyperpolarization of GT1-7 cells may be
dependent on ATP metabolism
Previously it has been suggested that oleate may inhibit
ATP-dependent gating of an acetylcholine-modulated
potassium channel (Kim and Pleumsamran, 2000). As
KATP channel activity is controlled to a large extent by
the ATP/ADP ratio in cells, with ATP-inhibiting and
ADP-activating KATP activity, respectively (Tucker and
Ashcroft, 1998), a simple explanation for the oleate-
mediated hyperpolarization could be reduced ATP-
dependent inhibition of channel activity. To examine this
possibility, we ﬁrst decided to replace ATP with the non-
hydrolyzable ATP analog, 50-adenylylimidodiphosphate
(AMP-PNP; 3 mM) in the pipette solution. The mean
GT1-7 cell resting membrane potential was signiﬁcantly
depolarized by the presence of AMP-PNP (Fig. 2G), com-
pared to control experiments in which ATP was allowed to
wash into the cell interior (compare with Fig. 2A). Further-
more, neither oleate (up to 200 lM) nor diazoxide
(250 lM) application to cells dialyzed with AMP-PNP
resulted in hyperpolarization of the membrane potential
(Fig. 2G), conﬂicting with the idea that oleate may act to
displace ATP from its inhibitory site on KATP. However,
these data suggest the requirement for ATP hydrolysis
for KATP activation, as previously demonstrated for dia-
zoxide in beta cells (Larsson et al., 1993).
Oleate reduced JC-1 mitochondrial membrane
potential ﬂuorescence without altering cellular
energy charge
Previous studies have indicated an important role for
uncoupling protein-2 (UCP2) as a regulator of KATP
channels in glucose-sensing neurons (Parton et al.,
2007), and oleate has been demonstrated to increase
levels of UCP2 in beta cells (Medvedev et al., 2002).
Increasing cellular UCP2 levels and activity would be
expected to diminish mitochondrial membrane potential
and respiration, via uncoupling, and so reduce ATP
levels, which could provide an explanation for oleate-
mediated activation of KATP in these neurons. We exam-
ined this possibility by inhibiting UCP2 activity pharmaco-
logically with genipin (Zhang et al., 2006), which has
previously been shown to reverse low glucose-mediated
hyperpolarization of pancreatic beta cells, GE-type
hypothalamic neurons and GT1-7 cells (Parton et al.,
2007; Beall et al., 2010; Beall et al., 2012). In contrast
we found that genipin was unable to reverse, or prevent,
oleate from hyperpolarizing GT1-7 neurons (Fig. 3A, B)
suggesting that UCP2 activity is not mediating oleate
action on these cells. However, on screening GT1-7 cells
for additional UCP isoforms we found that they also
express UCP4 and UCP5, although their protein levels
were not altered by oleate treatment (Fig. 3C). Conse-
quently, to explore further whether uncoupling by oleate
was a possible mechanism we assessed GT1-7 mito-
chondrial membrane potential using the membrane per-
meant mitochondrial dye, JC-1. Oleate signiﬁcantly
decreased JC-1 ﬂuorescence indicating depolarization
of the mitochondrial membrane potential (Fig. 3D) in a
time course that mimics oleate-mediated changes in
membrane potential and KATP current in these cells. To
determine whether the oleate-induced mitochondrial
depolarization reduced cellular energy charge, we mea-
sured both total cellular ATP and the ATP/ADP ratio. Nei-
ther measure was signiﬁcantly altered by exposure to
increasing concentrations of oleate (Fig. 3E, F), further
indicating that the activation of KATP channels by oleate
is unlikely to be caused by reduced ATP-mediated
inhibition.
Fig. 2. KATP activation by oleate is independent of AMPK, fatty acid oxidation and not mimicked by octanoic acid. (A) Eﬀect of oleate (100 lM) on
membrane potential of a GT1-7 cell in which malonyl-CoA (50 lM) was present in the electrode solution and allowed to dialyze into the cell for
20 min prior to oleate application. (B) Families of currents shown are from a holding potential of 70 mV with tests pulses between 160 and
20 mV and obtained at the marked times (d) during the experiment shown in (A). (C) Bar graph denotes mean slope conductance values (derived
from best ﬁt to current–voltage curves over 160 to 20 mV range) in control and in the presence of 100 lM oleate (n= 4), 10 and 20 min after
oleate addition. (D) Eﬀect of oleate (100 lM) on membrane potential of a GT1-7 cell in which etomoxir (100 lM) was present in the electrode
solution and allowed to dialyze into the cell for 20 min prior to oleate application. Bar graph shows mean values for membrane potential of untreated
(concurrently performed) cells (Cont), etomoxir (Etom) and Etom+ oleate (n= 4). (E) Octanoic acid (50 lM) reversibly depolarizes GT1-7 cell
membrane potential. Bar graph shows mean values for membrane potential of cells exposed to control (Cont), octanoic acid (OctA) and following
extensive washout of OctA (n= 8). (F) Oleate (100 lM) hyperpolarizes GT1-7 cells in the presence of OctA (50 lM), an action reversed by
tolbutamide (200 lM). Bar graph shows mean values for membrane potential of cells exposed to control (Cont), octanoic acid (OctA), OctA + oleate
and OctA + oleate + Tolb (n= 3–4). (G) The presence of AMP-PNP (3 mM) in the electrode solution (and thus dialyzed into cell) resulted in cell
depolarization and prevented hyperpolarization by oleate (100 lM) and DZX (250 lM). Bar graph shows mean values for membrane potential of
cells exposed to control (Cont: 2 min after formation of whole-cell conﬁguration and after 20-min dialysis, followed by the addition of oleate and
oleate + DZX (n= 4). (H). Calcium imaging traces following addition of BSA (control) of oleate (100 lM; n= 5). Values are means ± SEM.
*p< 0.05, ***p< 0.001
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Fig. 3. Oleate hyperpolarizes GT1-7 neurons independent of UCP2 activity but depolarizes the mitochondrial membrane potential. (A)
Representative perforated patch recording from a GT1-7 neuron showing that 100 lM oleate-induced hyperpolarization is unaﬀected by the
presence of 100 lM genipin, and depolarized by subsequent application of 200 lM tolbutamide. Bar graph shows mean values for membrane
potential of cells before and after application of oleate, followed by oleate + genipin and oleate + tolbutamide (n= 4). (B) Bar graph showing data
from similar experiment to (A), but with 100 lM genipin added prior to challenge with oleate + genipin, followed by oleate + tolbutamide (n= 3).
(C) Representative immunoblots showing the levels of UCP5, UCP4, p-ACC, p-AMPK and actin for control, vehicle (BSA) and oleate-treated cells.
(D) Confocal images of GT1-7 cells pre-incubated with JC-1 under control conditions and treated with oleate (100 lM) for 20 min. Conventional light
images of cells are shown on the right panels. Graph showing the change in JC-1 ﬂuorescence intensity with time (relative to starting point of
recording) for control (ﬁlled squares) and oleate-treated cells (n= 8). (E) GT1-7 total cellular ATP levels and (F) ATP:ADP ratios are unchanged by
the addition of oleate (10, 50 and 100 lM). Values are mean ± SEM. *p< 0.05, ***p< 0.001
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ARC neurons exhibit oleate and glucose sensitivity
We then sought to translate our ﬁndings in GT1-7 cells to
acute brain slice preparations from mice. First we
performed perforated patch recordings on unidentiﬁed
ARC neurons using a physiological extracellular glucose
concentration (2 mM) (de Vries et al., 2003; Silver and
Erecinska, 1994), similar to the recording conditions for
the GT1-7 cells. We used hypoglycemic challenge
(0.1 mM glucose) and subsequent changes in membrane
potential and ﬁring rates to identify GE- and GI-type neu-
rons, prior to challenge with oleate. Thus, when GE ARC
neurons were challenged with 0.1 mM glucose, they
responded, by hyperpolarization (from a Vm of 46.6
± 1.2 mV to 53.8 ± 1.5 mV (n= 20); P< 0.01), which
was reversible on return to 2 mM glucose solution
(Fig. 4A). Subsequent addition of 100 lM oleate resulted
in hyperpolarization (DVm= 7.0 ± 1.1 mV; P< 0.01)
and cessation of ﬁring in six out of 13 GE neurons tested,
with concomitant application of tolbutamide (200 lM)
reversing the hyperpolarization caused by the presence
of oleate. The remaining GE neurons were unaﬀected
by oleate (data not shown). Interestingly, in ARC neurons
that responded, reversibly, to 0.1 mM glucose by depolar-
ization (from a Vm of 49.3 ± 0.8 mV to 38.9 ± 1.7 mV
(n= 13; P< 0.01)) and were thus deemed GI-type, sub-
sequent application of 100 lM oleate exhibited depolar-
ization (DVm=+6.4 ± 1.2 mV) in four out of seven GI
neurons tested (Fig. 4B), with the remaining GI neurons
unaﬀected (data not shown). Neurons that displayed no
change in membrane potential or ﬁring rate to 0.1 mM glu-
cose challenge were similarly electrically unresponsive to
oleate (n= 5; data not shown). Consequently, subpopu-
lations of glucose-sensing GE and GI ARC neurons
respond to oleate, with the change in electrical excitability
mirroring the eﬀect of hypoglycemic levels of glucose.
As performed for GT1-7 cells, we also tested the eﬀect
of oleate on the electrical activity of mouse unidentiﬁed
ARC neurons using the whole-cell current-clamp
recording conﬁguration. Under these conditions the
mean resting membrane potential for ARC neurons was
52.9 ± 0.5 mV (n= 51), similar to that reported
previously for this recording mode in hypothalamic
neurons (Song et al., 2001; Ibrahim et al., 2003; Claret
et al., 2007). Bath application or pressure ejection of
oleate (100 lM) resulted in hyperpolarization (Fig. 4C),
with a mean DVm of 6.9 ± 0.6 mV (n= 32;
P< 0.001) and inhibition of ﬁring from 4.1 ± 0.4 Hz to
1.6 ± 0.4 Hz (P< 0.001). This inhibitory response was
accompanied by a decrease in the mean input resistance
from 2.13 ± 0.15 GX to 1.87 ± 0.16 GX (P< 0.05),
indicative of an increased cell conductance. Application
of tolbutamide (200 lM) in the continued presence of
oleate, reversed the hyperpolarization and inhibition of
ﬁring (Fig. 4C; n= 4; P< 0.01). In addition, naı¨ve ARC
neurons that responded with a small depolarization
(DVm=+2.8 ± 1.1 mV; n= 15; P< 0.05) and
increased ﬁring to the application of 200 lM tolbutamide
(indicating the presence of active KATP channels and so
likely to be GE-type) were shown to be unaﬀected by addi-
tion of 100 lM oleate in the continued presence of tolbu-
tamide (Fig. 4D). These data are in general agreement
with the GT1-7 ﬁndings and indicate that oleate can inhibit
neuronal ﬁring by activation of KATP channels in at least a
subpopulation of hypothalamic GE neurons. In a small
number of ARC neurons under these whole-cell recording
conditions we found that oleate caused depolarization
(DVm=+5.1 ± 0.7 mV; n= 6; P< 0.01), which
resulted in no signiﬁcant change in ﬁring frequency (4.4
± 1.4 Hz to 6.4 ± 0.8 Hz; n= 6; P= 0.09), possibly
because the depolarization was suﬃcient in some cases
to result in inactivation of voltage-gated sodium/calcium
channels and inhibit action potential generation (Fig. 4E).
DISCUSSION
Previous studies have produced disparate outcomes on
whether lipid-sensing hypothalamic neurons are also
glucose sensing. Wang and colleagues (Wang et al.,
2006) showed that there is minimal overlap between
oleate-sensing and glucose-sensing neurons in rat ARC
whereas Le Foll et al. (2009) demonstrated, using rat
VMN neurons, that many GE- and GI-type neurons were
excited and inhibited, respectively, by oleate (Wang et al.,
2006; Le Foll et al., 2009). We ﬁnd that glucose-sensing
ARC neurons are also oleate sensing in the same
direction with respect to change in excitability. Thus GE
neurons are inhibited by exposure to oleate and by
lowered extracellular glucose concentration, via a
KATP-dependent mechanism. Similarly, ARC neurons
depolarized by oleate are also depolarized by lowered
extracellular glucose concentration. These data indicate
that for these mouse ARC neurons at least, there is a
shared cellular response to increased lipid availability
and glucose deprivation. Thus it is likely that such neu-
rons play important roles in the modulation of physiologi-
cal responses to the fed-fasted transition and/or in the
pathophysiological outcomes associated with hypo-
glycemia and/or starvation. Both insulin-induced hypo-
glycemia and starvation are associated with increased
lipolysis (De Feo et al., 1989). However, lipid levels are
also elevated in the post-prandial period therefore per-
haps the glucose level stratiﬁes the physiological
response to increased lipid availability. Therefore, it is
possible that moderate changes in lipid availability con-
verge on these neuron populations to amplify an energy
deﬁcit signal or to enhance hepatic glucose production,
depending on glucose availability.
To investigate the intracellular mechanism(s)
responsible for oleate sensing in hypothalamic GE
neurons we utilized the mouse hypothalamic GnRH-
releasing GT1-7 neuronal cell line, which we have
recently characterized as a GE-type glucose-sensing
neuron (Beall et al., 2012), with glucose-sensing proper-
ties similar to that described for ARC neurons, including
POMC and AgRP neurons (Claret et al., 2007) and GnRH
neurons (Zhang et al., 2007). Challenging GT1-7s with ole-
ate elicited hyperpolarization and reduction or cessation of
ﬁring, which was reversed or prevented by tolbutamide,
indicating a KATP-dependent mechanism, similar to that
observed in ARC GE neurons under the same perforated
patch-recording conditions. As this outcomewas observed
on isolated GT1-7 cells, this suggests that the oleate
response is intrinsic to neurons and cell autonomous. We
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have previously shown that low glucose-induced opening
of KATP in mouse pancreatic beta cells, POMC neurons
and GT1-7 neurons is dependent on AMPK activity
(Claret et al., 2007; Beall et al., 2010; Beall et al., 2012).
Although oleate increases AMPK activity in GT1-7 cells
(similar to that observed for low-glucose stimulation), the
oleate-induced hyperpolarization of GT1-7 cells was not
prevented by the presence of the AMPK inhibitor, com-
pound C. Thus oleate-driven modulation of KATP channel
activity in GT1-7 neurons is likely mediated by a mecha-
nism distinct from that of hypoglycemia.
Interestingly, the oleate-induced neuronal
hyperpolarization reported here is in contrast to a
previous study, which demonstrated that oleate
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depolarized mouse ARC POMC neurons, which are GE-
type neurons (Ibrahim et al., 2003), by inhibition of KATP
channels, an outcome ascribed to increased mitochondrial
beta-oxidation of oleate and raised cellular ATP levels (Jo
et al., 2009). An alternativemechanismbywhichmitochon-
drial oxidation of oleate could increase KATP activity and
cause cell hyperpolarization is via the enhancedproduction
of reactive oxygen species (Larsson et al., 1996; Arany
et al., 2013; Gremmels, 2015). Importantly, the eﬀects of
oleate on energy and glucose homeostasis have been
shown to be dependent on hypothalamic CPT1 activity
(Obici et al., 2003; Pocai et al., 2006), indicative of fatty acid
oxidation regulating hypothalamic neurons. CPT1 is
endogenously inhibited by malonyl-CoA, the product of
the reaction carried out by acetyl CoA carboxylase. How-
ever, we found that oleate-inducedGT1-7 neuron hyperpo-
larization was not altered by direct intracellular application
of malonyl-CoA or by etomoxir, a pharmacological inhibitor
ofCPT1, suggesting that oleate-inducedKATP channel acti-
vation and subsequent hyperpolarization does not require
mitochondrial fatty acid metabolism. Furthermore, the
short-chain fatty acid, octanoic acid induced a signiﬁcant
depolarization of GT1-7 cells, but did not block the hyper-
polarizing action of oleate. Moreover, oleate did not alter
intracellular calcium in the GT1-7 cells, suggesting that
the oleate-induced changes are unlikely to be mediated
by CD36-driven store calcium release (Le Foll et al.,
2009) or conventional PKCs. Consequently, there is no
evidence to indicate that an alteration in fatty acid
beta-oxidation or fatty acid transport via CD36 is involved
in the oleate-mediated hyperpolarization of hypothalamic
neurons. Perhaps this is unsurprising as mitochondrial
FA metabolism predominantly generates ATP, which
would be expected to maintain KATP channel closure, as
described previously (Jo et al., 2009).
It has recently been suggested that coupling of the
extracellular glucose concentration to KATP in pancreatic
b-cells and GT1-7 neurons may also be dependent on
the expression and activity of UCP2 (Beall et al., 2010;
Beall et al., 2012). UCP2 acts to dissipate the proton gra-
dient across the mitochondrial membrane and is
expressed throughout the VMH (Parton et al., 2007) and
in GT1-7 cells (Beall et al., 2012). Furthermore, UCP2 is
activated by long-chain fatty acids (Jabu˚rek, 1999),
including oleate (Lameloise, 2001; Zackova et al., 2003)
or indirectly via fatty acid-induced production of reactive
oxygen species such as superoxide (Krauss et al.,
2003) or lipid peroxidation intermediates (Murphy et al.,
2003; Malingriaux et al., 2013). Thus oleate activation of
UCP2 is expected to decrease the mitochondrial mem-
brane potential and mitochondrial respiration, resulting
in reduction of cellular ATP levels. Acute pharmacological
inhibition of UCP2 with genipin did not prevent nor reverse
the oleate-induced hyperpolarization of GT1-7 neurons,
indicating that UCP2 does not play a role in oleate-
induced changes in membrane potential. Nonetheless,
indirect measurement of the mitochondrial membrane
potential indicated that oleate induced a mild uncoupling
of the mitochondrial membrane potential in a time course
that correlated with the activation of KATP. This led us to
screen GT1-7 neurons for other UCP isoforms, with
UCP4 and UCP5, the brain-enriched isoforms (Sanchis
et al., 1998; Mao et al., 1999), which display proton trans-
port capacity within lipid membranes (Hoang et al., 2012).
Both UCP4 and UCP5 were detected by immunoblotting,
although their expression was not signiﬁcantly modiﬁed
over the time course of the oleate treatment. Importantly
however, the reduced JC-1 ﬂuorescence caused by ole-
ate did not translate to a reduction in either total ATP
levels or a change in the ATP/ADP ratio. Therefore it is
possible that oleate quenched the JC-1 ﬂuorescence in
a non-speciﬁc manner (Mathur et al., 2000; Perry et al.,
2011) and that none of the UCP isoforms are involved
in oleate-induced KATP channel opening.
This leaves open the question of what intracellular
mechanism(s) mediates oleate-induced KATP channel
activation and hyperpolarization of GT1-7 and ARC GE
neurons. Since ATP levels are not altered and oleate
hyperpolarizes GE neurons and GT1-7 cells (where ATP
levels are clamped to maintain KATP channels closed), it
is unlikely that activation is mediated by a deﬁcit in ATP
availability. It is possible that oleate may reduce ATP
availability in the microdomain around the KATP channel
that is not detectable with whole-cell ATP measurements,
or that oleate (or a metabolite) alters KATP ATP sensitivity
or displaces ATP from the nucleotide binding domain of
the channel. An alternative possibility is that oleate is
converted to a long-chain fatty acyl CoA (LC–CoA) in
neurons. This process requires ATP hydrolysis and
LC–CoA molecules have been demonstrated to activate
KATP by binding to a speciﬁc site on the channel (Larsson
et al., 1996; Bra¨nstro¨m et al., 1997).
Fig. 4. Subpopulations of mouse ARC neurons respond electrically to oleate. (A) Representative perforated patch recording from a GE neuron, as
demonstrated by the reversible hyperpolarization elicited on switch from 2 mM to 0.1 mM glucose. Subsequent application of oleate (100 lM) in the
presence of 2 mM glucose hyperpolarizes this GE neuron. Addition of tolbutamide (200 lM) in the presence of oleate depolarizes the neuron. Note
the loss of action potentials in the presence of oleate + TOLB. Bar graph shows mean values (n= 6) for membrane potential of neurons exposed
to 2.0 mM and 0.1 mM glucose and 2 mM glucose + oleate. (B) Representative perforated patch recording from a GI neuron, as demonstrated by
the reversible depolarization elicited on switch from 2 mM to 0.1 mM glucose. Subsequent application of oleate (100 lM) in the presence of 2 mM
glucose depolarizes this GI neuron. Bar graph shows mean values (n= 4) for membrane potential of neurons exposed to 2.0 mM and 0.1 mM
glucose and 2.0 mM glucose + oleate. (C) Representative whole-cell current-clamp recording from an unidentiﬁed ARC neuron, with application of
100 lM oleate producing hyperpolarization of the membrane potential and inhibition of ﬁring, actions reversed by concomitant addition of
tolbutamide (200 lM). Bar graph shows mean values (n= 4) for membrane potential of neurons exposed to: Control (Cont), 100 lM oleate and
tolbutamide (TOLB). (D) Tolbutamide (200 lM) induced depolarization and increased ﬁring in an unidentiﬁed ARC neuron (indicating the presence
of active KATP channels) under whole-cell current-clamp. Subsequent addition of oleate (100 lM) had no eﬀect on membrane potential or ﬁring rate.
Bar graph shows mean values (n= 15) for membrane potential of neurons exposed to: Cont, TOLB and oleate + TOLB. (E) Representative whole-
cell current-clamp recording from an unidentiﬁed ARC neuron demonstrating the addition of oleate (100 lM) depolarized some neurons with an
overall decrease in ﬁring and truncation of action potential amplitude. Bar graph shows mean values (n= 13) for membrane potential of neurons in
Cont and exposed to oleate. Values are mean ± SEM. *p< 0.05, **p< 0.01, ***p< 0.001
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There are a number of limitations to our studies.
Firstly, we have not been able to address the
mechanism of oleate-induced depolarization in GI ARC
neurons, in large part due to the lack of a suitable cell
culture model. Therefore, the current that underlies
hypoglycemic and oleate-induced neuronal
depolarization remains elusive. A recent mouse model
developed by Stanley and colleagues (Stanley et al.,
2013) allowing identiﬁcation of GI neurons for slice elec-
trophysiology may be useful for identifying this current.
The concentration of oleate used here is larger than
that previously used in some studies of hypothalamic
glucose-sensing neurons (Wang et al., 2006; Le Foll
et al., 2009), although a recent study in humans mea-
sured an oleate level of >10 lM in the CSF of non-
obese humans (Levi et al., 2013). Furthermore, our data
demonstrating phosphorylation (inhibition) of ACC in
response to 100 lM oleate corresponds with that previ-
ously shown to inhibit ACC and fatty acid synthesis in
astrocytes (Natali et al., 2007). Therefore the concentra-
tion used here probably lies in the upper end of the phys-
iological level or in the pathophysiological range seen in
type 1 diabetes (Boden and G., 1998) and/or obesity.
However, there may be a number of reasons for the dis-
crepancies in oleate sensitivity. Previous studies have uti-
lized acutely dissociated VMH neurons, the preparation of
which may induce a stress response suﬃcient to alter the
sensitivity of these neurons to alternate fuel sources. Sec-
ondly, we have used whole-cell and perforated patch-
clamp studies to measure whole-cell macroscopic cur-
rents, membrane potential and ﬁring frequency whereas
other studies have utilized Ca2+ imaging. Indeed, oleate
can induce changes in intracellular calcium by mobilizing
[Ca2+]i stores (Carrillo et al., 2011), which may change
independently of cellular membrane potential, although
we did not observed in the current study.
The ability of oleate to reproduce the eﬀects of low
glucose on glucose-sensing neurons in the hypothalamus
might be expected to drive food intake and increase
hepatic glucose production since direct pharmacological
opening of hypothalamic KATP channels drives glucagon
and adrenaline release in the periphery during
hypoglycemia (Evans et al., 2004). However, central oleate
(under normoglycemic conditions) has been shown to inhi-
bit feeding and suppress glucose production, (Obici et al.,
2002; Cintra et al., 2012). This is further complicated by
the observation that the eﬀect of oleate on feeding and glu-
cose production requires the activity of KATP (Obici et al.,
2002), indicating that the action of oleate on feeding and
glucose production may utilize a similar intracellular mech-
anism described here. To examine this relation in more
detail, it would be interesting in future experiments to exam-
ine changes in ARC neuropeptide ratios (NPY/POMC and
AgRP/POMC) and counterregulatory hormone responses
to insulin-induced hypoglycemia under conditions of high
(oleate infusion) or low (acipimox-treated) plasma fatty acid
levels. It is plausible that separate subpopulations of ARC
neurons, which are involved in discrete physiological func-
tions (Lam et al., 2015; Burke, 2016) respond diﬀerentially
to oleate (by depolarization, hyperpolarization or no
response). Further analysis of electrophysiological
responses of identiﬁed ARC neurons to oleate and other
common dietary fatty acids, in conjunction with mouse
metabolic phenotypic analysis is required to resolve this
issue. Moreover, our studies did not examine the inﬂuence
of hormones on low glucose and oleate responses. It is
plausible that leptin, insulin and ghrelin, for example, mod-
ulate oleate and glucose responses, depending on the
physiological context of energy surfeit or deﬁcit.
In summary, we have demonstrated that the long-
chain unsaturated fatty acid, oleate alters the activity of
glucose-sensing hypothalamic neurons in a manner
similar to that of a hypoglycemic stimulus. Furthermore,
by utilizing a hypothalamic glucose-sensing cell line, we
show that oleate-induced KATP channel activation occurs
independently of changes in energy charge and may
involve an oleate metabolite that directly alters KATP
channel activity. The assimilation of fatty acid- and
glucose-sensing neuronal populations, along with the
inﬂuence of hormones such as insulin and leptin are
likely to be important drivers of an integrated
physiological response to changing nutrient availability.
Clearly, additional research is required to delineate the
network integration of glucose- and fatty acid-sensing
neurons within the hypothalamus and their relation to
energy homeostasis.
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